Greenwich Lifesciences Inc
(GLSI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 11,911 | 13,468 | 15,638 | 17,188 | 19,743 |
| TOTAL | $11,911 | $13,468 | $15,638 | $17,188 | $19,743 |
| Non-Current Assets | |||||
| Intangibles | 8 | 9 | 10 | 11 | 12 |
| TOTAL | $8 | $9 | $10 | $11 | $12 |
| Total Assets | $11,919 | $13,477 | $15,648 | $17,199 | $19,755 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 221 | 221 | 221 | 221 | 221 |
| Other current liabilities | 15 | 42 | 17 | 8 | 20 |
| TOTAL | $236 | $263 | $238 | $229 | $241 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $236 | $263 | $238 | $229 | $241 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 12,848 | 12,848 | 12,848 | 12,824 | 13,000 |
| Common Shares | 13 | 13 | 13 | 13 | 13 |
| Retained earnings | -43,598 | -41,473 | -38,682 | -36,363 | -35,617 |
| TOTAL | $11,684 | $13,214 | $15,410 | $16,970 | $19,514 |
| Total Liabilities And Equity | $11,919 | $13,477 | $15,648 | $17,199 | $19,755 |